Purpose | Board Meetings Date | Announcement Date |
---|---|---|
Board Meeting | 9 Oct 2025 | 3 Oct 2025 |
Covidh Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/10/2025 inter alia to consider and approve In continuation to our letter dated Friday October 03 2025 wherein the Board of Directors of the Company has approved Rights Issue of Equity Shares for an amount not exceeding Rs 808.56 Lakhs we wish to inform you that the approval of the Board of Directors of the Company will be sought on Thursday October 09 2025 to fix record date price entitlement ratio etc in relation to the Rights Issue as approved by the Board of the Company subject to receipt of approvals by stock exchange or such other regulatory authorities as may be required. This is with reference to our prior intimation dated October 03, 2025, regarding the meeting of the Board of Directors of Covidh Technologies Limited scheduled to be held today, i.e., Thursday, October 09, 2025, to consider and approve matters relating to the Rights Issue, including fixation of the record date, issue price, entitlement ratio, etc. We wish to inform you that the said Board Meeting has been deferred due to the delay in receipt of the In-Principle Approval from BSE Limited for the proposed Rights Issue. The Board shall consider and approve the aforesaid matters once the In-Principle Approval is received from the Exchange. (As Per BSE Announcement Dated on: 09/10/2025) | ||
Board Meeting | 3 Oct 2025 | 29 Sep 2025 |
Covidh Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/10/2025 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI Listing Regulations this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday October 03 2025 to consider inter-alia the proposal of fund raising by way of issue of equity shares or other securities of the Company through a rights issue and/or any other permissible mode as may be permitted under applicable law subject to such regulatory/statutory approvals as may be required and as may be deemed appropriate by the Company for its accelerated growth. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations), we wish to inform you that the Board of Directors of the Company in its meeting held today i.e. October 03, 2025, has, inter-alia, considered and approved the following: Raising of funds through the issuance of equity shares of face value ?10 each by way of rights issue for an amount not exceeding Rs 808.56 Lakhs, to the eligible equity shareholders of the Company as on the record date (to be determined and notified subsequently), subject to receipt of statutory / regulatory approvals in accordance with the amended SEBI (Issuer of Capital and Disclosure Requirements) Amendment Regulations, 2025 (the SEBI ICDR Regulations) and other applicable regulations and subject to necessary approvals as may be required. (As per BSE Announcement dated on: 03.10.2025) | ||
Board Meeting | 10 Sep 2025 | 10 Sep 2025 |
We Hereby inform the stakeholders that Ms. Deepakshi has been appointed as the Company Secretary cum Compliance Officer of the Company w.e.f. 09.10.2025 | ||
Board Meeting | 1 Aug 2025 | 29 Jul 2025 |
Covidh Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2025 inter alia to consider and approve 1. The Un-Audited Financial Results of the Company for the Quarter ended 30th June 2025. 2. Any other matter with the permission of the Chair. Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the Board of Directors of the Company at its meeting held on Friday, the 01st day of August, 2025 held via video conferencing which commenced at 03:00 P.M. and concluded at 07:45 P.M., to consider and approve the agendas given under the Outcome of Board Meeting. (As Per BSE Announcement Dated on: 01/08/2025) | ||
Board Meeting | 30 May 2025 | 27 May 2025 |
Covidh Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve 1. The Audited Financial Results of the Company for the Quarter and Financial Year ended 31st March 2025. 2. Any other matter with the permission of the Chair We herewith submit the outcome of the Board Meeting held today at 04:00 PM concluded at 04:45 PM to approve the audited financial results for the quarter and year ended 31.03.2025 along with other agendas (As per BSE Announcement Dated on 30/05/2025) | ||
Board Meeting | 25 Mar 2025 | 25 Mar 2025 |
Outcome of the board meeting held today | ||
Board Meeting | 10 Feb 2025 | 3 Feb 2025 |
COVIDH TECHNOLOGIES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2025 inter alia to consider and approve 1.To consider unaudited financial result for the third quarter 31 st December 2024 2. Any other business with the permission of chair. Outcome of Board Meeting Unaudited Financial Results for the quarter ended 31st December 2024 (As Per BSE Announcement Dated on 10/02/2025) | ||
Board Meeting | 13 Nov 2024 | 6 Nov 2024 |
COVIDH TECHNOLOGIES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve 1. To consider and approve the Un-Audited Financial Results for the Second Quarter and Half Year ended 30th September 2024 and limited review report thereon. 2. To consider any other business with the permission of the chair. Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Result For Quarter Ended 2024. (As Per Bse Announcement Dated on 13.11.2024) | ||
Board Meeting | 24 Oct 2024 | 24 Oct 2024 |
Intimation regarding Change in Management of the Company w.e.f 24.10.2024 Intimation regarding Change in Management of the Company w.e.f 24.10.2024 we are hereby submitting the Outcome of the Board Meeting held on 24.10.2024 as the appointment and resignation of directors took place in the Board. Board had approved the Corporate Office of the Company in the meeting held on 24.10.2024 |
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.